A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia
Clinical trial NCT04320615 · COMPLETED
Trial details
- NCT number
- NCT04320615
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-03
- Primary completion
- 2020-06-24
- Enrollment
- 452
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.